Connecting epigenetics and inflammation in vascular senescence: state of the art, biomarkers and senotherapeutics
Frontiers in Genetics · 26.02.2024 · 15
DOI: 10.3389/fgene.2024.1345459 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Genetics, online erschienen am 26.02.2024. Verfasst von Oscar Fraile-Martinez und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine and Medical Specialities, Faculty of Medicine and Health Sciences, University of Alcalá, Alcala deHenares, Spain. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 233 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Vascular diseases pose major health challenges, and understanding their underlying molecular mechanisms is essential to advance therapeutic interventions. Cellular senescence, a hallmark of aging, is a cellular state characterized by cell-cycle arrest, a senescence-associated secretory phenotype macromolecular damage, and metabolic dysregulation. Vascular senescence has been demonstrated to play a key role in different vascular diseases, such as atherosclerosis, peripheral arterial disease, hypertension, stroke, diabetes, chronic venous disease, and venous ulcers. Even though cellular senescence was first described in 1961, significant gaps persist in comprehending the epigenetic mechanisms driving vascular senescence and its subsequent inflammatory response. Through a comprehensive analysis, we aim to elucidate these knowledge gaps by exploring the network of epigenetic alterations that contribute to vascular senescence. In addition, we describe the consequent inflammatory cascades triggered by these epigenetic modifications. Finally, we explore translational applications involving biomarkers of vascular senescence and the emerging field of senotherapy targeting this biological process.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine and Medical Specialities, Faculty of Medicine and Health Sciences, University of Alcalá, Alcala deHenares, Spain.
- Ramón y Cajal Institute of Sanitary Research (IRYCIS), Madrid, Spain.
- Department of Surgery, Medical and Social Sciences, Faculty of Medicine and Health Sciences, University of Alcalá, Alcala deHenares, Spain.
- Network Biomedical Research Center for Liver and Digestive Diseases (CIBEREHD), Madrid, Spain.
- Immune System Diseases-Rheumatology, Oncology Service an Internal Medicine (CIBEREHD), University Hospital Príncipe de Asturias, Alcala deHenares, Spain.
- Department of General and Digestive Surgery, General and Digestive Surgery, Príncipe de Asturias Universitary Hospital, Alcala deHenares, Spain.
Zitieren
APA
Fraile-Martinez, O., De Leon-Oliva, D., Boaru, D. L., De Castro-Martinez, P., Garcia-Montero, C., Barrena-Blázquez, S., García-García, J., García-Honduvilla, N., Alvarez-Mon, M., Lopez-Gonzalez, L., Diaz-Pedrero, R., Guijarro, L. G., & Ortega, M. A. (2024). Connecting epigenetics and inflammation in vascular senescence: state of the art, biomarkers and senotherapeutics. Frontiers in Genetics, 15. https://doi.org/10.3389/fgene.2024.1345459
Vancouver
Fraile-Martinez O, De Leon-Oliva D, Boaru DL, De Castro-Martinez P, Garcia-Montero C, Barrena-Blázquez S, et al. Connecting epigenetics and inflammation in vascular senescence: state of the art, biomarkers and senotherapeutics. Frontiers in Genetics. 2024;15. doi:10.3389/fgene.2024.1345459
BibTeX
@article{FraileMartinez2024,
author = {Fraile-Martinez, Oscar and De Leon-Oliva, Diego and Boaru, Diego Liviu and De Castro-Martinez, Patricia and Garcia-Montero, Cielo and Barrena-Blázquez, Silvestra and García-García, Joaquin and García-Honduvilla, Natalio and Alvarez-Mon, Melchor and Lopez-Gonzalez, Laura and Diaz-Pedrero, Raul and Guijarro, Luis G and Ortega, Miguel A},
title = {Connecting epigenetics and inflammation in vascular senescence: state of the art, biomarkers and senotherapeutics},
journal = {Frontiers in Genetics},
year = {2024},
volume = {15},
doi = {10.3389/fgene.2024.1345459}
}
EUVIMED